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Ultraviolet A Radiation-Induced Immediate Iron Release Is a Key
Modulator of the Activation of NF-jB in Human Skin Fibroblasts
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Ultraviolet A (UVA, 320–400 nm) radiation, an oxidizing component of sunlight, leads to an immediate increase in
the labile iron in human skin ﬁbroblasts. Exposure of skin ﬁbroblasts to UVA radiation is also known to induce
nuclear factor-jB (NF-jB) DNA-binding activity, although the underlying mechanism is unclear. We report here that
in skin ﬁbroblasts, the extent of NF-jB activation by UVA tightly correlates with the level of ‘‘UVA-induced’’ labile
iron release as shown by both iron chelation and iron loading treatments. Furthermore, our data indicate that the
slow kinetics of induction of NF-jB by UVA relative to other oxidants previously studied is due to a transient
increase in permeability of nuclear membrane to proteins and occurs as a result of labile iron-mediated damage to
nuclear membrane. Since in addition to iron chelators, lipid peroxidation inhibitors also decrease the UVA-
mediated induction of NF-jB, we propose that the rapid release of labile iron by UVA might act as a catalyst to
exacerbate the generation of lipid secondary messengers in skin cell membranes that are responsible for induction
of NF-jB. This novel role for iron in amplifying NF-jB mobilization in response to UVA-induced oxidative stress
aids understanding of its involvement in UV-induced skin inﬂammation.
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Ultraviolet A radiation (UVA, 320–400 nm), an oxidizing
component of sunlight, exerts its biological effect mainly by
producing reactive oxygen species (ROS) such as singlet
oxygen (1O2) and hydrogen peroxide (H2O2) that promote
biological damage in exposed tissues via iron-catalyzed
oxidative reactions (Tyrrell, 1991; Vile and Tyrrell, 1995;
Tyrrell, 1996; Gasparro et al, 1998; Pourzand and Tyrrell,
1999). Several studies have demonstrated that low doses of
UVA radiation can induce lipid peroxidation in membranes
of human fibroblasts and keratinocytes via pathways
involving singlet oxygen and iron (Morliere et al, 1991;
Punnonen et al, 1991; Vile and Tyrrell, 1995). Indeed, the
capacity of readily exchanging electrons makes free
‘‘transit’’ (labile) iron potentially harmful, especially at
strategic cellular targets such as cell membranes, since it
can undergo redox cycling thereby generating toxic
oxidants such as hydroxyl radical and lipid-derived alkoxyl
and peroxyl radicals and elicit biological damage (Aust et al,
1985; Halliwell and Gutteridge, 1992). Cellular iron levels are
therefore tightly regulated by the cytosolic iron regulatory
proteins 1 and 2 (IRP) that function as post-transcriptional
regulators of both iron uptake via the transferrin receptor
(TfR) and iron sequestration by the iron storage protein,
ferritin (Ft). This regulation maintains iron homeostasis while
minimizing the pool of potentially toxic labile iron, the so-
called labile iron pool (LIP). Iron belonging to this intracel-
lular pool is considered to be in a steady-state equilibrium,
loosely bound to low molecular weight compounds such as
ATP or citrate, accessible to permeant chelators and
metabolically and catalytically reactive (Beinert and Kenne-
dy, 1993; Klausner et al, 1993; Kuhn, 1994; Guo et al, 1995;
Breuer et al, 1996; Hentze and Kuhn, 1996; Epsztejn et al,
1997; Cairo and Pietrangelo, 2000; Petrat et al, 2001).
Under conditions of oxidative stress, iron homeostasis
has been shown to be severely altered (Cairo et al, 1995;
Martins et al, 1995; Pantopoulos and Hentze, 1995; Cairo
et al, 1996). Furthermore, we have found that UVA irradia-
tion of the human skin fibroblasts FEK4 cells leads to
an immediate release of ‘‘labile’’ iron in the cells as a
consequence of oxidative damage to lysosomes and the
subsequent degradation of the iron storage protein, Ft
(Pourzand et al, 1999b). This finding is likely to be of crucial
importance to UVA-induced skin damage, because iron is
a catalyst of biological oxidations. The release of potential-
ly harmful free transit iron within the cells will clearly
exacerbate the damaging effects of photoperoxidation and
is likely to be of central importance to both reversible and
degenerative/pathological events that follow exposure to
solar UV radiation. The presence of excess iron has also
been demonstrated in a variety of skin pathologies that
involve inflammatory responses such as psoriasis (Molin
and Wester, 1973) and atopic eczema (Weintraub et al,
1965; David et al, 1990).
Abbreviations: BHT, butylated hydroxytoluene; DF, Desferal (des-
ferrioxamine mesylate); EMSA, electrophoretic mobility shift assay;
Fe-citrate, ferric citrate; Ft, ferritin; HO-2, heme oxygenase 2; IRP,
iron-regulatory protein; LIP, labile iron pool; NF-kB, nuclear factor-
kB; PBS, phosphate-buffered saline; ROS, reactive oxygen
species; SIH, salicylaldehyde isonicotinoyl hydrazone; UVA, ultra-
violet A
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The transcription factor nuclear factor-kB (NF-kB) is a
key regulator of the expression of many genes involved in
inflammation (Baeuerle, 1998). NF-kB exists in the form of
dimeric complexes consisting of different members of the
Rel family of proteins. The prototypical NF-kB is a
heterodimer composed of p65 (RelA) and p50 (NF-kB1).
Under most circumstances, NF-kB resides inactive in the
cytoplasm of unstimulated cells, by virtue of its interaction
with inhibitors of kB (IkB) family proteins such as IkBa
(Zabel and Baeuerle, 1990; Haskill et al, 1991; Beg and
Baldwin, 1993; Verma et al, 1995) that mask the nuclear
localization signal of NF-kB (Schreck et al, 1992; Baeuerle
and Henkel, 1994). A wide array of stimuli (Piette et al, 1997)
induces post-translational modifications of the IkB mole-
cule, ultimately leading to its degradation by the protea-
some. The free NF-kB then translocates to the nucleus
where it activates gene transcription.
Original studies on NF-kB focused on its role in
immunological and inflammatory responses (Liou and
Baltimore, 1993; Baeuerle and Henkel, 1994; Siebenlist et al,
1994; Baeuerle and Baichwal, 1997; Barnes and Karin,
1997). Several reports suggest that NF-kB is activated by
oxidative signalling (Schulze-Osthoff et al, 1995; Pahl and
Baeuerle, 1996; Pinkus et al, 1996) as both oxidants and
agents that generate intracellular ROS are able to induce
nuclear translocation of NF-kB (Schoonbroodt et al, 2000).
NF-kB is clearly sensitive to oxidoreductive modifications
occurring in cells and iron, which is capable of redox cycling
and production of ROS, appears to play a key role in NF-kB
activation. Indeed chelation of iron by the strong hydrophilic
drug desferrioxamine (Desferal, DF) has been shown to
suppress H2O2-induced NF-kB activation (Sappey et al,
1995). This process, however, appears to be selective as in
an unrelated study iron chelators DF, pyridoxal isonicotinoyl
hydrazone, and salicylaldehyde isonicotinoyl hydrazone
(SIH) showed no inhibition of TNF-a-induced NF-kB DNA-
binding activity (Lee et al, 1997). Furthermore, several
studies suggest that the general inhibitor of NF-kB,
pyrrolidine dithiocarbamate, a metal chelator and antiox-
idant, suppresses the NF-kB activation mainly as a result of
its metal-chelating properties (Bowie and O’Neill, 2000).
Since UVA in the physiological range of doses has been
shown to induce both the NF-kB DNA-binding activity (Vile
et al, 1995; Saliou et al, 1999) and labile iron release
(Pourzand et al, 1999b) in human skin cells, we hypothe-
sized that the UVA-induced immediate labile iron release
may be a key factor in UVA-mediated NF-kB activation in
human skin fibroblasts.
Results and Discussion
We have previously shown in this laboratory that UVA
radiation at doses within the physiological range activates
NF-kB DNA-binding activity in a concentration-dependent
manner in human skin fibroblasts FEK4 in culture (Vile et al,
1995). Activation was detected at doses as low as 100 kJ
per m2, which is equivalent to the amount the surface of the
skin would be exposed to over 30 min sunlight on a summer
day around noon at a northern latitude of 301–351 (Frederick
and Lubin, 1988). The response peaked around UVA doses
of 250–300 kJ per m2.
Using the same model system (FEK4 cells), we sought to
examine in detail the kinetics of DNA-binding activity of NF-
kB upon UVA irradiation (Fig 1a). Monolayer cultures of
exponentially growing FEK4 cells were exposed to a UVA
radiation dose of 250 kJ per m2 and nuclear extracts were
prepared at various times post-treatment. Binding activities
in the extracts capable of forming complexes with a
radiolabeled NF-kB oligonucleotide were assayed by
EMSA. In a representative gel of the kinetics experiment
(Fig 1a), the UVA-induced activation of NF-kB (p65:p50
heterodimer) DNA-binding activity appears as a slow
process, as the DNA-binding activity first decreases
gradually to below basal levels up to 2 h post-irradiation,
returns to basal level by 4 h and finally increases to reach a
peak of intensity between 6 and 8 h. The same experiment
was also repeated using earlier passage (3) FEK4 cells, with
an identical outcome (data not shown), demonstrating that
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Figure1
Time-course of nuclear factor-jB (NF-jB) DNA-binding activity and
steady-state levels of IjBa following ultraviolet A (UVA) radiation-
mediated oxidative stress. FEK4 cells were irradiated with a UVA
dose of 250 kJ per m2, collected at various times (0.25–12 h) post-
irradiation and used to prepare cytoplasmic and nuclear extracts. (a)
NF-kB and Oct-1 DNA-binding activities in the nuclear extracts were
analyzed by electrophoretic mobility shift assay (EMSA). (b) The
corresponding cytoplasmic extracts were assayed by western blot as
described in Materials and Methods for the levels of IkBa protein. The
cytoplasmic protein heme oxygenase-2 (HO-2) was used as a marker
of even loading. ‘‘C’’ indicates Control unirradiated cells. (c) The nuclear
extract prepared under (a) at 6 h post-irradiation was analyzed by
EMSA using competition and supershift experiments: Extracts were
preincubated as follows: with nothing (lane 3), with 50-fold excess of
unlabeled wild-type (lane 4) or mutated (lane 5) NF-kB oligonucleotide,
with antibodies (lanes 6 and 7), with preimmune serum (lane 8). Probe
(lane 1) indicates the reaction without cellular extract. DOC (lane 2) is a
cytoplasmic extract of unirradiated cells, treated with DOC and NP40
as described in Materials and Methods.
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the response of NF-kB to UVA radiation is not passage
dependent. Throughout this study, we observed a basal
level of nuclear NF-kB DNA-binding activity. This could be
due to the growing conditions and/or a cell-specific phenom-
enon. Low but detectable levels of NF-kB DNA-binding
activity have been reported in the literature in other cell
types, both primary (e.g. B cells), as well as non-primary, in
unstimulated conditions.
Since nuclear translocation of NF-kB to the nucleus
requires the degradation and/or release of IkBa molecule
from the complex with NF-kB, thereby unmasking the
nuclear localization signals of NF-kB subunits, we followed
the fate of IkBa (Fig 1b) by western analysis of cytoplasmic
extracts of UVA-irradiated cells. UVA radiation induced a
strong reduction in the apparent concentrations of the
protein within 15 min following the start of UVA irradiation,
contrasting with the slower activation of NF-kB observed in
Fig 1a. The disappearance of IkBa (Fig 1b) was followed by
resynthesis of the protein and a return to control values by
4–6 h post-irradiation.
Because NF-kB is a complex of proteins, various
combinations of Rel/NF-kB protein can constitute an active
NF-kB heterodimer that can bind to a specific sequence in
DNA. We therefore analyzed (Fig 1c), using competition and
supershift experiments, respectively, the binding specificity
and composition of the retarded complexes present in
nuclear extracts from UVA-irradiated cells and visualized by
EMSA in Fig 1a. The 6 h post-irradiation time point was
chosen for this analysis. The main complexes CI and CII
were shown to be specific and composed of p65:p50 and
p50:p50, respectively. Furthermore, treatment of a cyto-
plasmic extract of cells with the mild detergent DOC and
NP40, a procedure that is known to dissociate NF-kB from
its anchor protein IkBa (Baeuerle and Baltimore, 1988),
released a major complex that co-migrated with nuclear
complex CI. Taken together, these data indicate that
complex CI is indeed the p65:p50 heterodimer NF-kB,
and is activated by UVA radiation in FEK4 cells.
Since the rapid degradation of IkBa following exposure
of cells to UVA (Fig 1b) did not correlate timewise with the
pattern of activation of NF-kB in nuclear extracts (Fig 1a),
we hypothesized that UVA radiation, as a strong membrane
damaging agent may cause temporary damage to nuclear
membranes of FEK4 cells resulting in temporary loss of
compartmentalization of nuclear and cytoplasmic proteins,
leading to the leakage of nuclear proteins (including the
freshly translocated NF-kB) from the nucleus into the
cytosol. To test this hypothesis, our first approach was to
follow the DNA-binding activity of a purely nuclear tran-
scription factor, Oct-1 by EMSA in the nuclear extracts used
in Fig 1a. The results revealed that the decrease in DNA-
binding activity observed with NF-kB at 1–2 h post-
irradiation was also occurring with Oct-1 (Fig 1a). The latter
observation suggests that an event triggered by UVA could
change the behavior of both proteins already present in the
nucleus as well as proteins that translocate to the nucleus. It
is noteworthy that the lack of activation of Oct-1 by UVA at
late time points (i.e. 6–8 h post-irradiation) is consistent with
the previous observation by Schreck et al (1991) showing
that the DNA-binding activity of this transcription factor is
not induced by oxidative stress.
To test whether the apparent slow kinetics of NF-kB
activation by UVA was due to the loss of integrity of nuclear
membranes, we followed the subcellular localization of the
nuclear protein Oct-1 by immunofluorescence, 1 and 6 h
following UVA irradiation of FEK4 fibroblasts. The results
shown in Fig 2 revealed that 1 h following UVA irradiation,
the fluorescence staining of the nuclear protein spread into
the whole cell. At 6 h post-irradiation, however, fluores-
cence returned to a nuclear pattern and was similar to
unirradiated control cells. Using the same approach, we
also stained the cells with an antibody against the p65/RelA
subunit of NF-kB. As it can be seen in Fig 2, whereas p65
was essentially cytoplasmic in control unirradiated cells,
nuclear staining was clearly detectable at 6 h post-UVA
irradiation. The observation that some basal NF-kB DNA-
binding activity could be seen by EMSA in the nucleus of
unstimulated FEK4 cells in Fig 1a, whereas by immunocy-
tochemistry the majority of the factor appears cytoplasmic,
its natural location in most cell types, may be due to the
difference in sensitivities between these techniques. The
radiolabeled probe used in EMSA allows great sensitivity
and detection of very low levels of shifted complexes, a
sensitivity that cannot be reached with the immunocyto-
chemistry as employed in this study, but could be enhanced
by the use of confocal microscopy. These data, taken
together with the pattern of Oct-1 and NF-kB-binding
activities following UVA irradiation illustrated in Fig 1a, are
consistent with the delay observed between the disappear-
ance of IkBa in the cytoplasm and the appearance of NF-kB
in the nucleus upon UVA irradiation.
To further assess the hypothesis of protein leakage, we
analyzed the kinetics of activation of NF-kB following UVA
irradiation of fibroblasts by preparing total cell protein
p65
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Figure2
Effect of ultraviolet A (UVA) radiation on the cellular localization of
both p65 and Oct-1 proteins. FEK4 cells grown on coverslips were
UVA irradiated with a dose of 250 kJ per m2. At 1 and 6 h post-
irradiation, the cells were rinsed, fixed, and processed for immuno-
fluorescent detection of p65 and Oct-1, as described in Materials and
Methods. ‘‘C’’ indicates Control unirradiated cells.
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extracts (i.e. ‘‘totex’’ extracts) that, when assayed in EMSA,
measure the DNA-binding activity of NF-kB available from
both the cytoplasm and the nucleus, under the conditions
studied. As shown in Fig 3 (top panel), the induction of NF-
kB DNA-binding activity following UVA irradiation was no
longer slow, but rather fast and sustained from early points
(i.e. 0.25 h) up to 12 h post-irradiation time. These data
illustrate that the total NF-kB DNA-binding activity gener-
ated upon UVA irradiation does in fact mirror the pattern of
disappearance of IkBa, but because of the UVA-induced
damage to nuclear membranes leading to the transient
leakage of the freshly translocated NF-kB at early time
points following UVA irradiation, the effective DNA-binding
activity of NF-kB within the nucleus occurs only around 6 h
post-irradiation time. The ‘‘totex’’ extracts above were also
assayed by EMSA for total cellular Oct-1 DNA-binding
activity (Fig 3, bottom panel). The result shows that the latter
does not vary following UVA irradiation of FEK4 cells.
The observation (see Fig 1a and b) that NF-kB levels in
the nucleus are high and stabilized at a time when
normalization of IkBa protein is complete (i.e. 6–8 h post-
irradiation) was unexpected. A similar phenomenon can be
observed in separate studies. In the case of other agents
activating NF-kB via IkBa degradation (similarly to UVA
radiation), high NF-kB DNA-binding activity can still be
detected in nuclear extracts, long (sometimes hours) after
cytoplasmic IkBa protein levels have started to rise or even
have normalized (Shahrestanifar et al, 1999; Schoonbroodt
et al, 2000; Takada et al, 2003). But the reason for this is
unknown. It is possible that the sequestration of nuclear NF-
kB by de novo synthesized IkBa is strongly slowed and/or
hampered. At least four scenarios could explain this
phenomenon: (i) A nuclear protein could be bound to NF-
kB in the nucleus and prevent its sequestration by IkBa.
A candidate protein could be IkBb (another member of the
IkB inhibitory proteins). Indeed, IkBb in its 43 kDa unpho-
sphorylated isoform has been shown to bind NF-kB–DNA
complexes in the nucleus without inhibiting DNA-binding
capability of the factor (Suyang et al, 1996) and protect it
from dissociation by IkBa (Tran et al, 1997). It is possible
that IkBb undergoes UVA-mediated degradation like IkBa,
followed, however, by a slower resynthesis than its counter-
part, and migrates to the nucleus to prevent binding of IkBa
to NF-kB, thereby permitting the sustained NF-kB DNA-
binding activity (extending beyond 8 h post-irradiation) also
observed in Fig 3. (ii) It is also possible that the newly
synthesized IkBa pool, or at least some of it, binds to
proteins in the cytoplasm, thereby performing functions
distinct from the sequestering of NF-kB from the nucleus,
following cell stimulation. For instance, cytoplasmic se-
questration of histone deacetylases 1 and 3 by IkBa has
recently been shown to regulate positively the transcrip-
tional activity of homeodomain-containing proteins in
unstimulated cells (Viatour et al, 2003). (iii) Alternatively,
IkBa may be post-translationally modified when resynthe-
sized following UVA irradiation treatment, which may
prevent its subsequent binding to NF-kB. (iv) Finally, it is
plausible that following its UVA-induced degradation, IkBa
is quickly resynthesized but not properly folded, due to
damage to the endoplasmic reticulum machinery that
accompanies the general breakdown of cellular mem-
branes. IkBa would then not be able, even at late time
points (6–8 h post-irradiation) either to enter the nucleus, or
to efficiently bind NF-kB once in the nucleus. Considerable
further study will be required to define the precise mode of
action of UVA radiation on the IkB and NF-kB families of
proteins.
Since iron has been shown to contribute to UVA-
mediated peroxidation of human skin fibroblast mem-
branes, we hypothesized that the rapid increase in LIP
following UVA irradiation of cells (Pourzand et al, 1999b)
might play a key role in destabilization of the nuclear
membrane and the consequent leakage to the cytosol of the
freshly translocated NF-kB. To examine this hypothesis, we
first modulated the intracellular level of LIP by pre-treating
the cells either with the specific iron chelator DF (i.e. 100 mM
DF for 18 h), which is known to abolish the UVA-mediated
labile iron release (Pourzand et al, 1999b, and this study:
Table I) or with an iron-delivering compound (i.e. 4 mM hemin
for 18 h) that is capable of boosting several fold the level of
UVA-induced labile iron release within the human skin
fibroblast cells (Table I) and then correlated the results with
the extent of subcellular localization of the proteins of
interest, p65 and Oct-1 by immunofluorescence 1 and 6 h
following radiation treatment. The results (Fig 4a and b)
showed that at 1 h post-irradiation time, DF prevents
protein leakage of both p65 and Oct-1 between cell
compartments, whereas hemin (4 mM) enhances this
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Figure3
Kinetics of measurement of the total cellular nuclear factor-jB
(NF-jB) DNA-binding activity following ultraviolet A (UVA) irradia-
tion of FEK4 cells. FEK4 cells were UVA irradiated with a dose of
250 kJ per m2. Total cellular extracts (‘‘Totex’’) were prepared at the
indicated times post-irradiation and assayed in electrophoretic mobility
shift assay as described in Materials and Methods for NF-kB (top panel)
and Oct-1 (bottom panel) DNA-binding activity, respectively. ‘‘C’’ indi-
cates Control unirradiated cells.
Table I. Effect of iron chelation/loading on UVA-mediated
LIP release in FEK4 cells
FEK4 samples LIP (lM)
Control 1.06  0.13
UVA 2.25  0.27
DF 100 mM 0.00  0.00
DF 100 mMþUVA 0.03  0.03,þ
Hemin 4 mM 0.98  0.21
Hemin 4 mMþUVA 3.43  0.11,þ
Kd of CA–Fe for FEK4 was 12.7 mM. LIP measures were performed 0 h
after UVA treatment (250 kJ per m2), as indicated in Materials and
Methods. The concentrations of LIP are expressed as means  SD,
n¼6–11. UVA, ultraviolet A; LIP, labile iron pool; DF, Desferal.
Significantly different from control, po0.05.
þSignificantly different from UVA alone, po0.05.
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phenomenon when compared with UVA alone (see Fig 2).
Furthermore, at 6 h post-irradiation, whereas Oct-1 re-
mained unaffected by either compound, p65 translocation
was enhanced in cells pre-treated with hemin. These data
are consistent with the hypotheses that (1) the UVA-induced
increase in labile iron is responsible for UVA-mediated loss
of integrity of the nuclear membrane and the consequent
transient leakage of proteins between compartments and
(2) the UVA-induced labile iron release plays a role in the
UVA-mediated translocation of NF-kB to the nucleus.
To examine whether the modulation of the LIP following
UVA irradiation of fibroblasts plays a role in the UVA-
mediated induction of NF-kB-binding activity, we performed
EMSA (Fig 5a and b) with nuclear protein extracts of cells
that had been treated either with highly specific iron-
chelators or iron-delivering compounds prior to UVA
irradiation. For iron starvation, FEK4 cells were incubated
for 18 h either with the hydrophilic iron chelator DF (10 and
100 mM) or the lipophilic iron chelator SIH (10 and 100 mM;
Baker et al, 1992) prior to UVA irradiation with a dose of 250
kJ per m2. The results shown in Fig 5a revealed that
incubation of unirradiated cells with either compound had
no effect on the basal level of NF-kB DNA-binding activity.
But both DF and SIH were able to strongly reduce the level
of UVA-mediated NF-kB DNA-binding activity down to
that of the unirradiated control. These data reinforce our
hypothesis that the UVA-induced labile iron release is
involved in the pathway leading to the activation of NF-kB
in the human fibroblasts FEK4.
The experiment described above prompted us to further
investigate how an increase in the cellular LIP following UVA
irradiation may influence the UVA-mediated activation of
NF-kB. For this purpose, we loaded FEK4 cells with ferric
iron in the form of iron-citrate (Fe-citrate; 10 and 50 mM for
18 h) or hemin (4 mM for 18 h), prior to UVA irradiation with a
dose of 250 kJ per m2 (Fig 5b). The iron loading of cells for
18 h with either sources leads to IRP-regulated increase
in Ft synthesis (data not shown) that is responsible for
sequestering the excess labile iron, so following such long
treatment, the level of LIP returns to around control values.
But upon UVA irradiation and because of the immediate
degradation of higher levels of Ft in such iron-loaded cells
(Pourzand et al, 1999b), the level of labile iron release
increases dramatically (see Table I). The results, as shown
by EMSA (Fig 5b) revealed that neither Fe-citrate nor hemin
treatments alone had an effect on basal nuclear NF-kB
DNA-binding activity. Following UVA irradiation, however,
the level of NF-kB DNA-binding activity increased in a
concentration-dependent manner for cells treated with Fe-
citrate (10 and 50 mM) and hemin (4 mM). Taken together
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Figure 4
Effect of Desferal (DF) and hemin treatments on the cellular
localization of both p65 and Oct-1 following ultraviolet A (UVA)
irradiation of FEK4 cells. FEK4 cells were pre-treated with 10 mM DF
or 4 mM hemin as described in Materials and Methods and UVA
irradiated with a dose of 250 kJ per m2. At 1 and 6 h post-irradiation,
the cells were rinsed, fixed, and processed for immunofluorescent
detection of (a) p65 and (b) Oct-1. ‘‘C’’ indicates Control unirradiated
cells.
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Effect of the modulation of intracellular labile iron pool (LIP) on
nuclear factor-jB (NF-jB) DNA-binding activity. (a) FEK4 cells were
incubated in the presence of 10 and 100 mM of either Desferal (DF) or
salicylaldehyde isonicotinoyl hydrazone (SIH) for 18 h and ultraviolet
A (UVA) irradiated with a dose of 250 kJ per m2. NF-kB DNA-binding
activity in nuclear extracts prepared at 6 h post-irradiation was
analyzed by electrophoretic mobility shift assay as described in
Materials and Methods. (b) Cells were treated with Fe-citrate (10 and
50 mM) or hemin (4 and 20 mM) as described in Materials and Methods
and then UVA irradiated with a dose of 250 kJ per m2. Nuclear extracts
were prepared at 6 h post-irradiation and used for analysis of NF-kB
DNA-binding activity. ‘‘C’’ indicates Control unirradiated cells.
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these data strongly indicated that the extent of activation of
NF-kB by UVA is tightly associated with the intracellular
level of LIP and that the ‘‘UVA-induced’’ level rather than the
‘‘basal’’ level of LIP is responsible for the increased binding
activity of NF-kB.
These findings provide new information on the cellular
and molecular mechanisms underlying the UVA-mediated
induction of NF-kB. It appears that the activation of NF-kB
by UVA in skin fibroblast FEK4 cells occurs primarily via the
action of labile iron and involves the UVA-dependent
damage to membranes, according to the following events:
UVA irradiation of FEK4 cells causes an immediate
degradation of Ft and a consequent massive release of
labile iron. Since iron plays a crucial role in propagation of
peroxidative damage in cellular membranes, the pool of iron
liberated mainly by Ft and possibly other sources upon
irradiation, could not only initiate signaling events in the cell
membranes eventually leading to NF-kB activation, but also
produce concomitant damage to membranes, notably the
nuclear membrane, leading to protein leakage between
compartments. Several lines of evidence strengthen this
model. Firstly, UVA-mediated membrane damage in human
skin fibroblasts could be prevented in cells pre-treated with
iron chelators, and conversely could be enhanced in iron-
loaded cells (Morliere et al, 1991, 1997; Punnonen et al,
1991; Vile and Tyrrell, 1995). Secondly, UVA-mediated
activation of NF-kB appeared to be correlated with
membrane damage, since it could be prevented by the
membrane antioxidants BHT and a-tocopherol acetate as
previously demonstrated by Vile et al (1995) and as shown
in Fig 6, this study. Thirdly, it has been shown (Pourzand
et al, 1999b) that UVA irradiation at physiologically relevant
doses causes a transient loss of integrity of lysosomal
membranes, followed by a total recovery at 6–8 h post-
irradiation. The UVA-mediated loss of nuclear membrane
integrity and its recovery by 6 h post-irradiation time, as
illustrated in the immunofluorescence data presented in this
study, provides a rational explanation for the late appear-
ance of NF-kB in the nucleus, which starts beyond 4 h post-
irradiation and peaks at 6–8 h post-irradiation, in contrast
with the much faster (0.25 h or less) disappearance of the
IkBa protein. The apparent slow response of NF-kB to UVA
radiation is likely to have consequences on the kinetics of
activation of NF-kB target genes in the nucleus. More
generally, UVA-induced membrane damage and transient
loss of compartmentalization may affect gene expression as
a whole. Interestingly and in line with this notion, UVA-
mediated transcriptional upregulation of most genes stu-
died so far occurs several hours following irradiation
treatment (Tyrrell, 1996; Soriani et al, 1998).
The mechanism we propose in this study is very relevant
in skin since the latter is an important site of iron turnover
(Trenam et al, 1992). Furthermore, NF-kB plays a pivotal role
of in inflammation, infection, responses to stress, and as
member of a protooncogene family. Increased levels of iron
are found in several skin disorders that involve inflammatory
responses such as psoriasis and atopic eczema. Further-
more, many genes, including several protooncogenes, are
upregulated by physiological doses of UVA and/or UVB
radiation (Soriani et al, 1998; Bose et al, 1999). Several
genes that are activated by oxidative stress, and by UVA in
particular, are regulated by NF-kB. The products of several
of these genes participate directly or indirectly in inflamma-
tory processes (e.g. IL-6, IL-8, TNFa, and collagenase) and
may explain some of the effects of exposure to solar UV. We
believe that this study should contribute to a better
understanding of the mechanisms underlying gene activa-
tion following acute or long-term exposure to UVA radiation.
Furthermore, these findings in human skin cells provide the
first such account of the involvement of labile iron as a key
factor in the UVA-mediated activation of NF-kB and suggests
possible pathways to protection through iron chelation.
Materials and Methods
Cell culture and irradiation The human skin fibroblast cells FEK4
(3.5  105; passages 12–14) were grown in 10 cm dishes for 3 d in
order to reach 80% confluency on the day of the experiment as
described previously (Tyrrell and Pidoux, 1988). Irradiations were
performed in phosphate-buffered saline (PBS)/Ca2þ /Mg2þ at
approximately 251C as described previously (Pourzand et al,
1999b). After irradiation, the saved medium was added back to the
dishes and cells were incubated at 371C in a 5% CO2 atmosphere
for the times indicated in the legends. Fibroblasts monolayers were
irradiated with different doses (0–300 kJ per m2) of UVA, using a
broad spectrum Sellas 4 kW UVA lamp (Sellas, Gerelsberg,
Germany). The incident dose rate was 350 W per m2. The UV
doses were measured using an IL1700 radiometer (International
Light, Newbury, Massachusetts). Control fibroblasts were treated
in the same manner, except that they were not irradiated.
Chemicals Unless otherwise specified, all reagents were from
Sigma Chemical (St Louis, Missouri). Cell cultures materials were
from Life Technologies (Paisley, Scotland) except FCS, which was
from PAA Laboratories (Teddington, UK) and PBS, which was from
Oxoid (Basingstoke, UK). Stock solutions were prepared in PBS,
except DF (Desferal from CIBA-GEIGY, Basel, Switzerland) in
water, SIH (a kind gift from P. Ponka, Lady Davis Institute for
Medical Research, Montreal, Canada), hemin in dimethyl sulfoxide,
and butylated hydroxytoluene (BHT) in ethanol. Final concentration
of dimethyl sulfoxide or ethanol in the medium did not exceed
0.2%. The complex of ferric citrate (Fe-citrate) was freshly
prepared as described by Pourzand et al (1999a). a-tocopherol
acetate was in the state of an oil (Tm¼ 251C) in the conditions of
the experiment (371C). Poly [d(I–C)] and the protease inhibitors
(PMSF, E-64, leupeptin, pepstatin, and aprotinin) were prepared
according to the manufacturer’s instructions (Boehringer, Man-
nheim, Germany). Water used to prepare PBS and other stock
BHT  [µM]
α-toco [µM] _          _ 100
NF-κB
_         _ 100
_ 25 _ _ 25  _
UVA [kJ/m2]     C  250
Figure 6
Effect of membrane antioxidants butylated hydroxytoluene (BHT)
and a-tocopherol acetate on ultraviolet A (UVA)-mediated activa-
tion of nuclear factor-jB (NF-jB). FEK4 cells were pre-treated with
BHT (25 mM) or a-tocopherol acetate (a-toco) (100 mM) for 18 h and UVA
irradiated with a dose of 250 kJ per m2. NF-kB DNA-binding activity in
the nuclear extracts was analyzed by electrophoretic mobility shift
assay at 6 h post-irradiation. ‘‘C’’ indicates Control unirradiated cells.
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solutions was issued from a Millipore purification system (Millipore,
Bedford, Massachusetts) in order to minimize the presence of
trace elements such as transition metals.
Treatments DF, SIH, Fe-citrate, and hemin were added at the
indicated concentrations to the conditioned medium, 18 h prior to
irradiation.
Calcein loading and intracellular LIP estimation The method
used to estimate the level of intracellular calcein-bound iron (CA–
Fe) was modified from Epsztejn et al (1997) as described previously
(Pourzand et al, 1999b). To determine the intracellular level of LIP,
that is operationally defined as the sum of the intracellular level of
Calcein-bound iron (i.e., [CA–Fe]) and free iron (i.e., [Fe] unbound to
CA), the cell-dependent dissociation constant (Kd) for CA–Fe was
obtained by addition of known amounts of ferrous ammonium
sulfate to the system and monitoring intensity of the fluorescence
changes of the Calcein (CA) versus the metal concentration (i.e.
titration). From the Kd value, the absolute intracellular level of free
iron (i.e. [Fe] unbound to CA) was then calculated and the results
were expressed as micromolar concentration of LIP (i.e. [CA–
Fe]þ [Fe]).
Electrophoretic mobility shift assay (EMSA) Cytoplasmic and
nuclear fractions of cell lysates were prepared as described by
Schreiber et al (1989). Where indicated in the legends, total cell
protein extracts (i.e. ‘‘totex’’ extracts) were prepared according to
Baeuerle and Baltimore (1988). Buffers were supplemented freshly
with the protease inhibitors PMSF (1 mM), E-64, leupeptin and
pepstatin (10 mg per mL each) and aprotinin (1 mg per mL) and the
phosphatase inhibitors b-glycerophosphate (20 mM), sodium
orthovanadate (10 mM) and sodium fluoride (1 mM). Protein
concentration was measured using the method of Bradford (BIO-
RAD, Hercules, California; Bradford, 1976). The decameric ‘‘kB’’
motif was the high-affinity site of the mouse k light chain enhancer
(Zabel et al, 1991). The sequence of the Oct-1 oligonucleotide and
the binding conditions are described elsewhere (Schreiber et al,
1988). The NF-kB bandshifts were performed as described by
Vile et al (1995). For supershift experiments, antibodies directed
against either p50 (a kind gift from Dr A. Israel) or p65/RelA
(generously provided by Dr P. A. Baeuerle) subunits of NF-kB were
used. For competition experiments, 50-fold molar excess of
unlabeled oligonucleotide (either wild-type or mutated) was added
to the protein mix, 10 min prior to addition of the probe. Activation
of cytoplasmic NF-kB DNA-binding activity was achieved by
treating the cytoplasmic extract with 0.8% sodium deoxycholate
(DOC) followed by 1% of the non-ionic detergent Nonidet P-40
(NP40), prior to incubation with the probe. Results are shown as
autoradiograms using standard films (Amersham, Bucks, UK), or
as scans obtained with a PhosphorImager (Molecular Dynamics,
Sunnyvale, California) using IMAGEQUANT software (National
Institutes of Health, Bethesda, Maryland).
Immunoblotting Cytoplasmic and nuclear extracts used for
western analysis were generated as described above. Equal
amounts of proteins (10 mg) were resolved on a 10% SDS-
polyacrylamide gel, transferred onto a nitrocellulose membrane
(Amersham) and processed according to manufacturer’s instruc-
tions. The rabbit anti-IkBa antibody from Santa Cruz Biotechnology
(Santa Cruz, California) and a mouse anti-HO-2 (heme oxygenase
2) antiserum (this laboratory) were used. The antibody–antigen
complexes were revealed with either a horseradish peroxidase-
conjugated goat anti-rabbit or goat anti-mouse antibody (Jackson
ImmunoResearch, West Grove, PA) and visualized by chemilumi-
nescence (ECL from Amersham Biosciences, Bucks, UK).
Immunoﬂuorescence Cells were grown on sterile glass cover-
slips in the conditions described in the Cell culture and irradiation
section, then pre-treated or not and irradiated. Following irradia-
tion, medium was removed at the times indicated in the legends
and cells were fixed for 5 min in ice-cold methanol and
subsequently rehydrated in PBS at room temperature for 10 min.
Blocking of non-specific sites was carried out for 10 min in
blocking solution (PBSþ 0.1% Triton X-100þ 2% BSA). The
primary antibodies used (Santa Cruz) were either the rabbit anti-
p65(A), or the rabbit anti-Oct-1(C-21) and were incubated with the
cells for 30 min in the above blocking solution. Cells were washed
four times in PBS and incubated for 30 min with the secondary
antibody, a goat anti-rabbit FITC-conjugated IgG (Sigma Che-
mical). Washings were repeated as above and antifade 1,4-
diazabicyclo [2.2.2]octane (DABCO, 100 mg per mL solution in
10% PBS:90% glycerol) (DABCO Poole, Dorset, UK) was added
on the coverslips that were finally mounted. Slides were analyzed
by epifluorescence on a Nikon Optiphot-2 microscope (Nikon UK
Limited, Kingstone Upon Tyne, UK) using excitation at 495 nm and
emission at 525 nm.
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